235 related articles for article (PubMed ID: 21216633)
1. TCL-SPION-enhanced MRI for the detection of lymph node metastasis in murine experimental model.
Lim SW; Kim HW; Jun HY; Park SH; Yoon KH; Kim HS; Jon S; Yu MK; Juhng SK
Acad Radiol; 2011 Apr; 18(4):504-11. PubMed ID: 21216633
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
3. [Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].
Xue HD; Lei J; Li Z; Wang DT; Zhou WX; Dai W; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):139-45. PubMed ID: 19507589
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model.
Choi SH; Kim KH; Moon WK; Kim HC; Cha JH; Paik JH; Chang KH
J Magn Reson Imaging; 2010 Jan; 31(1):134-41. PubMed ID: 20027581
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
Mack MG; Balzer JO; Straub R; Eichler K; Vogl TJ
Radiology; 2002 Jan; 222(1):239-44. PubMed ID: 11756732
[TBL] [Abstract][Full Text] [Related]
7. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
Harisinghani MG; Saksena MA; Hahn PF; King B; Kim J; Torabi MT; Weissleder R
AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
[TBL] [Abstract][Full Text] [Related]
9. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
Ross MR; Schomer DF; Chappell P; Enzmann DR
AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
[TBL] [Abstract][Full Text] [Related]
11. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
Pandharipande PV; Mora JT; Uppot RN; Goehler A; Braschi M; Halpern EF; Gazelle GS; Harisinghani MG
AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
[TBL] [Abstract][Full Text] [Related]
12. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
13. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
14. In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles.
Iida S; Imai K; Matsuda S; Itano O; Hatakeyama M; Sakamoto S; Kokuryo D; Okabayashi K; Endo T; Ishii Y; Hasegawa H; Aoki I; Handa H; Kitagawa Y
J Magn Reson Imaging; 2013 Dec; 38(6):1346-55. PubMed ID: 23554026
[TBL] [Abstract][Full Text] [Related]
15. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
16. [Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph nodes in rabbit models].
Feng Y; Zhang GX; Wang H; Hu YS; Wang XF; Zheng LF
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):813-8. PubMed ID: 21223685
[TBL] [Abstract][Full Text] [Related]
17. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
[TBL] [Abstract][Full Text] [Related]
18. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
[TBL] [Abstract][Full Text] [Related]
20. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
